Âé¶¹Ô´´ Analysis and Insights: Global Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´
The global Veterinary Infectious Disease Diagnostics market is projected to grow from US$ 1886.9 million in 2024 to US$ 2887.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 94%.
Report Covers:
This report presents an overview of global market for Veterinary Infectious Disease Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Veterinary Infectious Disease Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Veterinary Infectious Disease Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Infectious Disease Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Veterinary Infectious Disease Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Veterinary Infectious Disease Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Âé¶¹Ô´´ Segmentation
By Company
IDEXX Laboratories
Zoetis
Qiagen
Thermo Fisher Scientific
Neogen Corporation
Virbac
Randox Laboratories
IDVet
Heska Corporation
Creative Diagnostics
URIT Medical Electronic Group
NTBIO Diagnostics
Bio-X Diagnostics
Segment by Type
Immunodiagnostics
ELISA
Segment by Application
Lab
Hospital
Clinics
PoC
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Veterinary Infectious Disease Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Infectious Disease Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Infectious Disease Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Immunodiagnostics
1.2.3 ELISA
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Lab
1.3.3 Hospital
1.3.4 Clinics
1.3.5 PoC
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Global Veterinary Infectious Disease Diagnostics Growth Trends by Region
2.2.1 Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Veterinary Infectious Disease Diagnostics Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Veterinary Infectious Disease Diagnostics Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Dynamics
2.3.1 Veterinary Infectious Disease Diagnostics Industry Trends
2.3.2 Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Drivers
2.3.3 Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Challenges
2.3.4 Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Veterinary Infectious Disease Diagnostics by Players
3.1.1 Global Veterinary Infectious Disease Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Veterinary Infectious Disease Diagnostics Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Veterinary Infectious Disease Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Infectious Disease Diagnostics Revenue in 2023
3.5 Global Key Players of Veterinary Infectious Disease Diagnostics Head office and Area Served
3.6 Global Key Players of Veterinary Infectious Disease Diagnostics, Product and Application
3.7 Global Key Players of Veterinary Infectious Disease Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Infectious Disease Diagnostics Breakdown Data by Type
4.1 Global Veterinary Infectious Disease Diagnostics Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Veterinary Infectious Disease Diagnostics Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Veterinary Infectious Disease Diagnostics Breakdown Data by Application
5.1 Global Veterinary Infectious Disease Diagnostics Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Veterinary Infectious Disease Diagnostics Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type
6.2.1 North America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type (2019-2024)
6.2.2 North America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type (2025-2030)
6.2.3 North America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Share by Type (2019-2030)
6.3 North America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application
6.3.1 North America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application (2019-2024)
6.3.2 North America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application (2025-2030)
6.3.3 North America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Share by Application (2019-2030)
6.4 North America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Country
6.4.1 North America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Country (2019-2024)
6.4.3 North America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type
7.2.1 Europe Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type (2019-2024)
7.2.2 Europe Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type (2025-2030)
7.2.3 Europe Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Share by Type (2019-2030)
7.3 Europe Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application
7.3.1 Europe Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application (2019-2024)
7.3.2 Europe Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application (2025-2030)
7.3.3 Europe Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Share by Application (2019-2030)
7.4 Europe Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Country
7.4.1 Europe Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Country (2019-2024)
7.4.3 Europe Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size (2019-2030)
8.2 China Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type
8.2.1 China Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type (2019-2024)
8.2.2 China Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type (2025-2030)
8.2.3 China Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Share by Type (2019-2030)
8.3 China Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application
8.3.1 China Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application (2019-2024)
8.3.2 China Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application (2025-2030)
8.3.3 China Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size (2019-2030)
9.2 Asia Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type
9.2.1 Asia Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type (2019-2024)
9.2.2 Asia Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type (2025-2030)
9.2.3 Asia Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Share by Type (2019-2030)
9.3 Asia Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application
9.3.1 Asia Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application (2019-2024)
9.3.2 Asia Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application (2025-2030)
9.3.3 Asia Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Share by Application (2019-2030)
9.4 Asia Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Region
9.4.1 Asia Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Region (2019-2024)
9.4.3 Asia Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East, Africa, and Latin America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type
10.2.1 Middle East, Africa, and Latin America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application
10.3.1 Middle East, Africa, and Latin America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Country
10.4.1 Middle East, Africa, and Latin America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Veterinary Infectious Disease Diagnostics Âé¶¹Ô´´ Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 IDEXX Laboratories
11.1.1 IDEXX Laboratories Company Details
11.1.2 IDEXX Laboratories Business Overview
11.1.3 IDEXX Laboratories Veterinary Infectious Disease Diagnostics Introduction
11.1.4 IDEXX Laboratories Revenue in Veterinary Infectious Disease Diagnostics Business (2019-2024)
11.1.5 IDEXX Laboratories Recent Developments
11.2 Zoetis
11.2.1 Zoetis Company Details
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Veterinary Infectious Disease Diagnostics Introduction
11.2.4 Zoetis Revenue in Veterinary Infectious Disease Diagnostics Business (2019-2024)
11.2.5 Zoetis Recent Developments
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Veterinary Infectious Disease Diagnostics Introduction
11.3.4 Qiagen Revenue in Veterinary Infectious Disease Diagnostics Business (2019-2024)
11.3.5 Qiagen Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Veterinary Infectious Disease Diagnostics Introduction
11.4.4 Thermo Fisher Scientific Revenue in Veterinary Infectious Disease Diagnostics Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Neogen Corporation
11.5.1 Neogen Corporation Company Details
11.5.2 Neogen Corporation Business Overview
11.5.3 Neogen Corporation Veterinary Infectious Disease Diagnostics Introduction
11.5.4 Neogen Corporation Revenue in Veterinary Infectious Disease Diagnostics Business (2019-2024)
11.5.5 Neogen Corporation Recent Developments
11.6 Virbac
11.6.1 Virbac Company Details
11.6.2 Virbac Business Overview
11.6.3 Virbac Veterinary Infectious Disease Diagnostics Introduction
11.6.4 Virbac Revenue in Veterinary Infectious Disease Diagnostics Business (2019-2024)
11.6.5 Virbac Recent Developments
11.7 Randox Laboratories
11.7.1 Randox Laboratories Company Details
11.7.2 Randox Laboratories Business Overview
11.7.3 Randox Laboratories Veterinary Infectious Disease Diagnostics Introduction
11.7.4 Randox Laboratories Revenue in Veterinary Infectious Disease Diagnostics Business (2019-2024)
11.7.5 Randox Laboratories Recent Developments
11.8 IDVet
11.8.1 IDVet Company Details
11.8.2 IDVet Business Overview
11.8.3 IDVet Veterinary Infectious Disease Diagnostics Introduction
11.8.4 IDVet Revenue in Veterinary Infectious Disease Diagnostics Business (2019-2024)
11.8.5 IDVet Recent Developments
11.9 Heska Corporation
11.9.1 Heska Corporation Company Details
11.9.2 Heska Corporation Business Overview
11.9.3 Heska Corporation Veterinary Infectious Disease Diagnostics Introduction
11.9.4 Heska Corporation Revenue in Veterinary Infectious Disease Diagnostics Business (2019-2024)
11.9.5 Heska Corporation Recent Developments
11.10 Creative Diagnostics
11.10.1 Creative Diagnostics Company Details
11.10.2 Creative Diagnostics Business Overview
11.10.3 Creative Diagnostics Veterinary Infectious Disease Diagnostics Introduction
11.10.4 Creative Diagnostics Revenue in Veterinary Infectious Disease Diagnostics Business (2019-2024)
11.10.5 Creative Diagnostics Recent Developments
11.11 URIT Medical Electronic Group
11.11.1 URIT Medical Electronic Group Company Details
11.11.2 URIT Medical Electronic Group Business Overview
11.11.3 URIT Medical Electronic Group Veterinary Infectious Disease Diagnostics Introduction
11.11.4 URIT Medical Electronic Group Revenue in Veterinary Infectious Disease Diagnostics Business (2019-2024)
11.11.5 URIT Medical Electronic Group Recent Developments
11.12 NTBIO Diagnostics
11.12.1 NTBIO Diagnostics Company Details
11.12.2 NTBIO Diagnostics Business Overview
11.12.3 NTBIO Diagnostics Veterinary Infectious Disease Diagnostics Introduction
11.12.4 NTBIO Diagnostics Revenue in Veterinary Infectious Disease Diagnostics Business (2019-2024)
11.12.5 NTBIO Diagnostics Recent Developments
11.13 Bio-X Diagnostics
11.13.1 Bio-X Diagnostics Company Details
11.13.2 Bio-X Diagnostics Business Overview
11.13.3 Bio-X Diagnostics Veterinary Infectious Disease Diagnostics Introduction
11.13.4 Bio-X Diagnostics Revenue in Veterinary Infectious Disease Diagnostics Business (2019-2024)
11.13.5 Bio-X Diagnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
IDEXX Laboratories
Zoetis
Qiagen
Thermo Fisher Scientific
Neogen Corporation
Virbac
Randox Laboratories
IDVet
Heska Corporation
Creative Diagnostics
URIT Medical Electronic Group
NTBIO Diagnostics
Bio-X Diagnostics
Ìý
Ìý
*If Applicable.